BANK OF AMERICA CORP /DE/ - BELLICUM PHARMACEUTICALS INC ownership

BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 98 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 4.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$13,000
-7.1%
10,001
-20.6%
0.00%
Q3 2019$14,000
-84.6%
12,598
-76.3%
0.00%
Q2 2019$91,000
-75.9%
53,175
-52.5%
0.00%
Q1 2019$377,000
-4.1%
111,886
-17.0%
0.00%
Q4 2018$393,000
+601.8%
134,777
+1394.2%
0.00%
Q3 2018$56,000
-37.1%
9,020
-26.0%
0.00%
Q2 2018$89,000
-15.2%
12,190
-23.7%
0.00%
Q1 2018$105,000
+22.1%
15,984
+57.0%
0.00%
Q4 2017$86,000
-47.2%
10,182
-28.1%
0.00%
Q3 2017$163,000
+61.4%
14,159
+63.7%
0.00%
Q2 2017$101,000
+16.1%
8,649
+22.8%
0.00%
Q1 2017$87,000
+11.5%
7,041
+23.1%
0.00%
Q4 2016$78,000
+90.2%
5,720
+173.7%
0.00%
Q3 2016$41,000
+13.9%
2,090
-24.7%
0.00%
Q2 2016$36,000
+414.3%
2,776
+271.6%
0.00%
Q1 2016$7,000
-98.7%
747
-97.2%
0.00%
Q4 2015$536,000
+206.3%
26,425
+119.6%
0.00%
Q3 2015$175,000
-24.2%
12,033
+11.0%
0.00%
Q2 2015$231,000
-12.5%
10,841
-4.7%
0.00%
Q1 2015$264,000
+13100.0%
11,378
+11278.0%
0.00%
Q4 2014$2,0001000.00%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
EMORY UNIVERSITY 95,215$1,297,0001.28%
Baker Brothers Advisors 4,865,647$66,270,0000.65%
Eventide Asset Management 250,000$3,405,0000.22%
MCDANIEL TERRY & CO 76,112$1,037,0000.22%
SUFFOLK CAPITAL MANAGEMENT LLC 82,538$1,124,0000.15%
QVT Financial LP 337,923$4,603,0000.14%
KENNEDY CAPITAL MANAGEMENT LLC 478,465$6,517,0000.11%
Vident Investment Advisory, LLC 47,157$642,0000.08%
Tekla Capital Management LLC 60,000$817,0000.04%
First Eagle Investment Management, LLC 775,254$10,559,0000.03%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders